FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366406605> ?p ?o ?g. }

• W4366406605 endingPage "138" @default.
• W4366406605 startingPage "138" @default.
• W4366406605 abstract "Primary mediastinal B-cell lymphomas (PMBL) are aggressive B- cell lymphomas. Although the initial treatment models vary in PMBL, appropriate treatment methods are not known. We aim to show real-life data on health outcomes in adult patients with PMBL who received various type of chemoimmunotherapies in Turkey.We analyzed the data of 61 patients who received treatments for PMBL from 2010 to 2020. The overall response rate (ORR), overall survival (OS) and progression-free survival (PFS) of the patients were evaluated.61 patients were observed in this study. The mean age of the study group was 38.4 ± 13.5 years. From among them, 49.2% of the patients were female (n = 30). For first-line therapy, 33 of them had received rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen (54%). Twenty-five patients had received rituximab, etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA-EPOCH-R) regimen. The ORR was 77%. The median OS and PFS were as follows: 25 months (95% CI: 20.4-29.4) and 13 months (95% CI: 8.6-17.3), respectively. The OS and PFS at 12 months were 91.3% and 50%, respectively. The OS and PFS at five years were 64.9% and 36.7%, respectively. Median follow-up time period was 20 months (IQR 8.5-38.5).R-CHOP and DA-EPOCH-R showed good results in PMBL. These remain one of the best determined systemic treatment options for first-line therapy. Also, the treatment was associated with good efficacy and tolerability." @default.
• W4366406605 created "2023-04-21" @default.
• W4366406605 creator A5005309444 @default.
• W4366406605 creator A5007875818 @default.
• W4366406605 creator A5009497243 @default.
• W4366406605 creator A5012145024 @default.
• W4366406605 creator A5014496457 @default.
• W4366406605 creator A5015151478 @default.
• W4366406605 creator A5017541582 @default.
• W4366406605 creator A5020222160 @default.
• W4366406605 creator A5034622760 @default.
• W4366406605 creator A5035266400 @default.
• W4366406605 creator A5044011322 @default.
• W4366406605 creator A5046624985 @default.
• W4366406605 creator A5048386558 @default.
• W4366406605 creator A5051141719 @default.
• W4366406605 creator A5056131873 @default.
• W4366406605 creator A5058897783 @default.
• W4366406605 creator A5059887072 @default.
• W4366406605 creator A5072344712 @default.
• W4366406605 creator A5073299475 @default.
• W4366406605 creator A5076943240 @default.
• W4366406605 creator A5079612401 @default.
• W4366406605 creator A5085646762 @default.
• W4366406605 creator A5089139363 @default.
• W4366406605 creator A5089751759 @default.
• W4366406605 creator A5090952599 @default.
• W4366406605 date "2023-01-01" @default.
• W4366406605 modified "2023-10-16" @default.
• W4366406605 title "Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study" @default.
• W4366406605 cites W2001196047 @default.
• W4366406605 cites W2967569980 @default.
• W4366406605 cites W2979952645 @default.
• W4366406605 cites W3080277143 @default.
• W4366406605 cites W3126620286 @default.
• W4366406605 cites W3144452350 @default.
• W4366406605 cites W3197875123 @default.
• W4366406605 cites W3204661520 @default.
• W4366406605 cites W3215795610 @default.
• W4366406605 cites W4205675679 @default.
• W4366406605 cites W4210627762 @default.
• W4366406605 cites W4213430480 @default.
• W4366406605 doi "https://doi.org/10.4103/jcrt.jcrt_355_22" @default.
• W4366406605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37147993" @default.
• W4366406605 hasPublicationYear "2023" @default.
• W4366406605 type Work @default.
• W4366406605 citedByCount "0" @default.
• W4366406605 crossrefType "journal-article" @default.
• W4366406605 hasAuthorship W4366406605A5005309444 @default.
• W4366406605 hasAuthorship W4366406605A5007875818 @default.
• W4366406605 hasAuthorship W4366406605A5009497243 @default.
• W4366406605 hasAuthorship W4366406605A5012145024 @default.
• W4366406605 hasAuthorship W4366406605A5014496457 @default.
• W4366406605 hasAuthorship W4366406605A5015151478 @default.
• W4366406605 hasAuthorship W4366406605A5017541582 @default.
• W4366406605 hasAuthorship W4366406605A5020222160 @default.
• W4366406605 hasAuthorship W4366406605A5034622760 @default.
• W4366406605 hasAuthorship W4366406605A5035266400 @default.
• W4366406605 hasAuthorship W4366406605A5044011322 @default.
• W4366406605 hasAuthorship W4366406605A5046624985 @default.
• W4366406605 hasAuthorship W4366406605A5048386558 @default.
• W4366406605 hasAuthorship W4366406605A5051141719 @default.
• W4366406605 hasAuthorship W4366406605A5056131873 @default.
• W4366406605 hasAuthorship W4366406605A5058897783 @default.
• W4366406605 hasAuthorship W4366406605A5059887072 @default.
• W4366406605 hasAuthorship W4366406605A5072344712 @default.
• W4366406605 hasAuthorship W4366406605A5073299475 @default.
• W4366406605 hasAuthorship W4366406605A5076943240 @default.
• W4366406605 hasAuthorship W4366406605A5079612401 @default.
• W4366406605 hasAuthorship W4366406605A5085646762 @default.
• W4366406605 hasAuthorship W4366406605A5089139363 @default.
• W4366406605 hasAuthorship W4366406605A5089751759 @default.
• W4366406605 hasAuthorship W4366406605A5090952599 @default.
• W4366406605 hasBestOaLocation W43664066051 @default.
• W4366406605 hasConcept C121332964 @default.
• W4366406605 hasConcept C126322002 @default.
• W4366406605 hasConcept C1276947 @default.
• W4366406605 hasConcept C141071460 @default.
• W4366406605 hasConcept C143998085 @default.
• W4366406605 hasConcept C150846664 @default.
• W4366406605 hasConcept C197934379 @default.
• W4366406605 hasConcept C2776694085 @default.
• W4366406605 hasConcept C2776755627 @default.
• W4366406605 hasConcept C2778119113 @default.
• W4366406605 hasConcept C2778375690 @default.
• W4366406605 hasConcept C2778720950 @default.
• W4366406605 hasConcept C2779338263 @default.
• W4366406605 hasConcept C2779429289 @default.
• W4366406605 hasConcept C2780317896 @default.
• W4366406605 hasConcept C2780653079 @default.
• W4366406605 hasConcept C2780739268 @default.
• W4366406605 hasConcept C2781413609 @default.
• W4366406605 hasConcept C71924100 @default.
• W4366406605 hasConcept C90924648 @default.
• W4366406605 hasConceptScore W4366406605C121332964 @default.
• W4366406605 hasConceptScore W4366406605C126322002 @default.
• W4366406605 hasConceptScore W4366406605C1276947 @default.
• W4366406605 hasConceptScore W4366406605C141071460 @default.

• next